hydroxyproline has been researched along with Hypercalcemia in 72 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Hypercalcemia: Abnormally high level of calcium in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The biologically active form of vitamin D3, calcitriol, is effective in the treatment of psoriasis but can alter calcium metabolism." | 9.08 | Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. ( Goffe, BS; Guzzo, C; Katz, HI; Lazarus, G; Lowe, NJ; Pincus, SH, 1996) |
| "The superiority of pamidronate in controlling hypercalcemia is mirrored by the changes observed in these markers." | 9.08 | Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. ( Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J, 1997) |
| "Following a four-day control period during which an elevated serum calcium level either stabilized or continued to rise despite maximally tolerated saline diuresis, 12 patients with neoplastic hypercalcemia were treated with intravenous etidronate disodium (etidronate) 7." | 7.67 | Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium. ( Clemens, TL; Gordon, AC; Gundberg, CM; Jacobs, TP; Reich, L; Shane, E; Silverberg, SJ, 1987) |
| "Osteocalcin (serum bone-Gla protein, sBGP), serum alkaline phosphatase (sAP) and urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) have been measured in 21 patients with primary hyperparathyroidism (PHPT) and in nine patients with hypercalcaemia of malignancy (HM)." | 7.67 | Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. ( de la Piedra, C; Rapado, A; Toural, V, 1987) |
| "The amounts of total hydroxyproline (THP), free hydroxyproline (FHP) and non-dialysable hydroxyproline (NDHP) excreted in the urine by six patients with chronic renal failure who received kidney transplants and six patients with primary hyperparathyroidism were studied." | 7.65 | Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism. ( Dixon, SR; Goulding, A; McChesney, R, 1977) |
| " We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer." | 7.65 | Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976) |
| "The biologically active form of vitamin D3, calcitriol, is effective in the treatment of psoriasis but can alter calcium metabolism." | 5.08 | Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. ( Goffe, BS; Guzzo, C; Katz, HI; Lazarus, G; Lowe, NJ; Pincus, SH, 1996) |
| "The superiority of pamidronate in controlling hypercalcemia is mirrored by the changes observed in these markers." | 5.08 | Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. ( Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J, 1997) |
| " Eight of these patients had either hypercalcemia or hypercalciuria, and all 10 had elevated urinary hydroxyproline levels as evidence of active skeletal disease." | 5.05 | Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton. ( Canfield, RE; Hyman, GA; Siris, ES, 1983) |
| "We evaluated the serum osteocalcin and alkaline phosphatase levels and the urinary hydroxyproline excretion in patients with blastic, lithic or mixed metastases, humoral malignant hypercalcemia (HMH) and myeloma." | 3.68 | [Bone turnover markers in tumor pathology with bone involvement]. ( Amado Señarís, JA; González Macías, J; Napal Lecumberri, J; Pesquera, C; Riancho, JA, 1990) |
| "We have measured classic markers of bone turnover, serum alkaline phosphatase (sAP), urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) and osteocalcin (sBGP), in two bone disorders characterized by an increase in bone remodelling, namely Paget's disease of bone and primary hyperparathyroidism (PHPT) and in two other bone diseases characterized by an increase in bone resorption without the concomitant increase in bone formation, hypercalcaemia of malignancy (HM) and involutional osteoporosis (IO)." | 3.67 | Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis. ( de la Piedra, C; Rapado, A; Torres, R, 1989) |
| "Following a four-day control period during which an elevated serum calcium level either stabilized or continued to rise despite maximally tolerated saline diuresis, 12 patients with neoplastic hypercalcemia were treated with intravenous etidronate disodium (etidronate) 7." | 3.67 | Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium. ( Clemens, TL; Gordon, AC; Gundberg, CM; Jacobs, TP; Reich, L; Shane, E; Silverberg, SJ, 1987) |
| "Osteocalcin (serum bone-Gla protein, sBGP), serum alkaline phosphatase (sAP) and urinary hydroxyproline/creatinine ratio (uOH-Prol/creatinine) have been measured in 21 patients with primary hyperparathyroidism (PHPT) and in nine patients with hypercalcaemia of malignancy (HM)." | 3.67 | Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. ( de la Piedra, C; Rapado, A; Toural, V, 1987) |
| "Calcitonin (CT) plasma levels and urinary hydroxyproline (OHPr) excretion were studied in twenty-eight patients (eleven males and seventeen females) with primary hyperparathyroidism in order to ascertain the effect of CT secretion on the severity of bone disease." | 3.66 | Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. ( Alberti, LM; D'Erasmo, E; Mancini, D; Mazzuoli, GF; Minisola, S; Scarda, A; Valtorta, C, 1981) |
| "The amounts of total hydroxyproline (THP), free hydroxyproline (FHP) and non-dialysable hydroxyproline (NDHP) excreted in the urine by six patients with chronic renal failure who received kidney transplants and six patients with primary hyperparathyroidism were studied." | 3.65 | Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism. ( Dixon, SR; Goulding, A; McChesney, R, 1977) |
| " We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer." | 3.65 | Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976) |
| "Amongst the bone resorption markers studied are: 1) Calcium/creatinine urinary quotient; 2) Tartrate resistant acid phosphatase; 3) Urinary hydroxyproline; 4) Other substance derived from collagen disruption such as hydroxylysine glycoside, piridinolinic intermolecular bridges and the enzymatic activity of proline iminopeptidase." | 2.38 | [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]. ( de la Piedra Gordo, C; Torres Jiménez, R, 1990) |
| "Malignant hypercalcemia is caused by both increased bone resorption and enhanced tubular reabsorption of calcium." | 1.28 | Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone. ( Burckhardt, P; Jaeger, P; Thiebaud, D, 1990) |
| "Dogs with lymphosarcoma and hypercalcemia had decreased trabecular bone volume and increased osteoclastic osteolysis, whereas dogs with lymphosarcoma that were normocalcemic did not have increased bone resorption." | 1.27 | Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations. ( Capen, CC; Chew, DJ; Kociba, GJ; Levine, L; Meuten, DJ; Nagode, LA; Segre, GV; Tashjian, AH; Voelkel, EF, 1983) |
| "Biochemical evaluation showed that bone resorption from metastatic disease was generally not enough to account for hypercalcaemia." | 1.27 | Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. ( Boyle, IT; Fogelman, I; Gardiner, MD; Ralston, SH, 1984) |
| "This was associated with a decrease in bone resorption as judged by decreases in urinary excretion of hydroxyproline and calcium." | 1.27 | Treatment of the hypercalcaemia of malignancy with intravenous clodronate. ( Gray, RE; Greaves, M; Hamdy, NA; Kanis, JA; McCloskey, EV; Neil, FE; Preston, FE; Urwin, GH; Yates, AJ, 1987) |
| "This hypercalcemia was accompanied by marked urinary hydroxyproline excretion and less calcium excretion in the urine than the prevailing level of serum calcium." | 1.27 | Hypercalcemia in glucocorticoid withdrawal. ( Fukumoto, Y; Ichihara, K; Itoh, Y; Miyazaki, A; Moriwaki, K; Nonaka, K; Seino, Y; Suzuki, K; Tarui, S; Yamada, Y, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (81.94) | 18.7374 |
| 1990's | 13 (18.06) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimich, A | 1 |
| Brown, S | 1 |
| Minkowitz, S | 1 |
| Wallach, S | 1 |
| Douglas, DL | 2 |
| Duckworth, T | 1 |
| Russell, RG | 2 |
| Kanis, JA | 7 |
| Preston, CJ | 1 |
| Preston, FE | 3 |
| Prenton, MA | 1 |
| Woodhead, JS | 1 |
| Siris, ES | 3 |
| Hyman, GA | 1 |
| Canfield, RE | 3 |
| Paterson, AD | 1 |
| Cameron, EC | 1 |
| Beard, DJ | 1 |
| Charhon, S | 1 |
| Chapuy, MC | 1 |
| Valentin-Opran, A | 1 |
| Edouard, C | 1 |
| Rosini, S | 1 |
| Meunier, PJ | 1 |
| Fairney, A | 1 |
| Littledike, ET | 1 |
| Horst, RL | 2 |
| Meuten, DJ | 1 |
| Kociba, GJ | 1 |
| Capen, CC | 3 |
| Chew, DJ | 1 |
| Segre, GV | 1 |
| Levine, L | 1 |
| Tashjian, AH | 1 |
| Voelkel, EF | 1 |
| Nagode, LA | 1 |
| Portmann, L | 2 |
| Häfliger, JM | 1 |
| Bill, G | 1 |
| Burckhardt, P | 3 |
| Ralston, SH | 1 |
| Fogelman, I | 1 |
| Gardiner, MD | 1 |
| Boyle, IT | 1 |
| Jacobs, TP | 3 |
| Bilezikian, JP | 1 |
| Baquiran, DC | 1 |
| Shane, E | 2 |
| Mazzuoli, GF | 1 |
| D'Erasmo, E | 1 |
| Scarda, A | 1 |
| Mancini, D | 1 |
| Minisola, S | 1 |
| Alberti, LM | 1 |
| Valtorta, C | 1 |
| Graham, JJ | 1 |
| Harding, PE | 1 |
| Hoare, LL | 1 |
| Thomas, DW | 1 |
| Wise, PH | 1 |
| Plosker, GL | 1 |
| Goa, KL | 1 |
| Mazières, B | 1 |
| Laroche, M | 1 |
| Cantagrel, A | 1 |
| Ishimura, E | 1 |
| Miki, T | 1 |
| Koyama, H | 1 |
| Harada, K | 1 |
| Nakatsuka, K | 1 |
| Inaba, M | 1 |
| Nishizawa, Y | 1 |
| Morii, H | 2 |
| Guzzo, C | 1 |
| Lazarus, G | 1 |
| Goffe, BS | 1 |
| Katz, HI | 1 |
| Lowe, NJ | 1 |
| Pincus, SH | 1 |
| Vinholes, J | 1 |
| Guo, CY | 1 |
| Purohit, OP | 1 |
| Eastell, R | 1 |
| Coleman, RE | 2 |
| Magnuson, SK | 1 |
| Booth, R | 1 |
| Porter, S | 1 |
| Gorski, JP | 1 |
| Goulding, A | 2 |
| Broom, MF | 1 |
| van Breukelen, FJ | 1 |
| Bijvoet, OL | 3 |
| van Oosterom, AT | 1 |
| Jaffiol, C | 1 |
| Piperno, M | 1 |
| Baldet, L | 1 |
| Robin, M | 1 |
| Mirouze, J | 1 |
| Kistler, H | 1 |
| McChesney, R | 1 |
| Dixon, SR | 1 |
| Rosen, JF | 1 |
| Wolin, DA | 1 |
| Finberg, L | 1 |
| Coombes, RC | 2 |
| Powles, TJ | 2 |
| Gazet, JC | 1 |
| Ford, HT | 1 |
| Nash, AG | 1 |
| Sloane, JP | 1 |
| Hillyard, CJ | 1 |
| Thomas, P | 1 |
| Keyser, JW | 1 |
| Marcus, D | 1 |
| Zinberg, N | 1 |
| Stimson, WH | 1 |
| Neville, AM | 2 |
| Pavlova, L | 1 |
| Bondy, PK | 1 |
| Wada, S | 1 |
| Kitamura, H | 1 |
| Matsuura, Y | 1 |
| Katayama, Y | 1 |
| Ohkawa, H | 1 |
| Kugai, N | 1 |
| Motoyoshi, K | 1 |
| Fuse, Y | 1 |
| Nagata, N | 1 |
| Rotstein, S | 1 |
| Glas, U | 1 |
| Eriksson, M | 1 |
| Pfeiffer, P | 1 |
| Hansen, J | 1 |
| Söderqvist, J | 1 |
| Bandmann, U | 1 |
| Strid, S | 1 |
| Zysset, E | 1 |
| Ammann, P | 1 |
| Jenzer, A | 1 |
| Gertz, BJ | 1 |
| Rizzoli, R | 1 |
| Jaquet-Müller, F | 1 |
| Pryor-Tillotson, S | 1 |
| Bonjour, JP | 1 |
| Bickerstaff, DR | 1 |
| O'Doherty, DP | 1 |
| McCloskey, EV | 3 |
| Hamdy, NA | 4 |
| Mian, M | 1 |
| de la Piedra Gordo, C | 1 |
| Torres Jiménez, R | 1 |
| Thiebaud, D | 1 |
| Jaeger, P | 1 |
| Napal Lecumberri, J | 1 |
| Amado Señarís, JA | 1 |
| Pesquera, C | 1 |
| Riancho, JA | 1 |
| González Macías, J | 1 |
| Torres, R | 1 |
| de la Piedra, C | 2 |
| Rapado, A | 2 |
| Ryzen, E | 1 |
| Rea, TH | 1 |
| Singer, FR | 2 |
| Urwin, GH | 2 |
| Yates, AJ | 2 |
| Gray, RE | 4 |
| Greaves, M | 1 |
| Neil, FE | 1 |
| McCloskey, E | 1 |
| Galloway, J | 2 |
| Rattenbury, JM | 1 |
| Brown, CB | 1 |
| Rosol, TJ | 1 |
| Weisbrode, SE | 1 |
| Body, JJ | 1 |
| Borkowski, A | 1 |
| Cleeren, A | 1 |
| Godsall, JW | 1 |
| Burtis, WJ | 1 |
| Insogna, KL | 1 |
| Broadus, AE | 1 |
| Stewart, AF | 1 |
| Gordon, AC | 1 |
| Silverberg, SJ | 1 |
| Reich, L | 1 |
| Clemens, TL | 1 |
| Gundberg, CM | 1 |
| Beneton, MN | 1 |
| Murray, SA | 1 |
| Conte, N | 1 |
| Di Virgilio, R | 1 |
| Roiter, I | 1 |
| Caberlotto, L | 1 |
| Baglin, TP | 1 |
| Boughton, BJ | 1 |
| Toural, V | 1 |
| Rubens, RD | 1 |
| Suzuki, K | 1 |
| Nonaka, K | 1 |
| Ichihara, K | 1 |
| Fukumoto, Y | 1 |
| Miyazaki, A | 1 |
| Yamada, Y | 1 |
| Itoh, Y | 1 |
| Seino, Y | 1 |
| Moriwaki, K | 1 |
| Tarui, S | 1 |
| Stevens, MJ | 1 |
| Percival, RC | 1 |
| Rogers, K | 1 |
| Neal, FE | 1 |
| van der Sluys Veer, J | 1 |
| Jansen, AP | 1 |
| Tanae, A | 1 |
| Ibayashi, H | 1 |
| Nakao, K | 1 |
| Elias, EG | 1 |
| Evans, JT | 1 |
| Fisher, G | 1 |
| Skillern, PG | 1 |
| de Moor, P | 1 |
| Bouillon, R | 1 |
| Knill-Jones, RP | 1 |
| Buckle, RM | 1 |
| Parsons, V | 1 |
| Calne, RY | 1 |
| Williams, R | 1 |
| Goldsmith, RS | 1 |
| Katz, CM | 1 |
| Tzagournis, M | 1 |
| Avioli, LV | 1 |
| Lee, CA | 1 |
| Lloyd, HM | 1 |
| Ahnfeldt-Mollerup, I | 1 |
| Rowland, GN | 1 |
| Black, HE | 1 |
| Young, DM | 1 |
| Martin, TJ | 1 |
| Melick, RA | 1 |
| Neer, RM | 1 |
| Murray, TM | 1 |
| Keutmann, HT | 1 |
| Deftos, LJ | 1 |
| Potts, JT | 1 |
| Cochran, M | 1 |
| Peacock, M | 1 |
| Sachs, G | 1 |
| Nordin, BE | 1 |
| Trzenschik, K | 1 |
| Mühlbach, R | 1 |
| Corbeel, L | 1 |
| Casaer, P | 1 |
| Malvaux, P | 1 |
| Lormans, J | 1 |
| Bourgeois, N | 1 |
| MacManus, J | 1 |
| Heaton, FW | 1 |
| Bell, NH | 1 |
| Colwell, JA | 1 |
| Saval, F | 1 |
| Del Greco, F | 1 |
| Casey, DE | 1 |
| Bonadonna, G | 1 |
| Merlino, MJ | 1 |
| Myers, WP | 1 |
| Sonenberg, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for hydroxyproline and Hypercalcemia
| Article | Year |
|---|---|
The use of biochemical tests in the diagnosis of disorders of calcium metabolism.
Topics: Acid Phosphatase; Adult; Alkaline Phosphatase; Calcitonin; Calcium; Calcium Metabolism Disorders; Ch | 1980 |
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose | 1994 |
[Primary hyperparthyroidism. Analysis of 152 patients with special reference to acute life threatening complications (acute hyperparathyroidism)].
Topics: Acute Disease; Adenoma; Adolescent; Adrenal Glands; Adult; Aged; Alkaline Phosphatase; Body Weight; | 1976 |
[Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
Topics: Acid Phosphatase; Adult; Biomarkers; Bone Resorption; Child; Female; Follow-Up Studies; Humans; Hydr | 1990 |
Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
Topics: Adenylyl Cyclases; Alkaline Phosphatase; Animals; Bone Neoplasms; Calcium; Cyclic AMP; Disease Model | 1986 |
The diagnosis of primary hyperparathyroidism.
Topics: Alkaline Phosphatase; Calcium; Cortisone; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism | 1968 |
7 trials available for hydroxyproline and Hypercalcemia
| Article | Year |
|---|---|
Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clini | 1983 |
Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
Topics: Administration, Cutaneous; Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcitriol; Ca | 1996 |
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Neoplasms; Bone Resorption; Calcium; C | 1997 |
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic | 1992 |
Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Doub | 1992 |
Dichloromethylene diphosphonate action in hematologic and other malignancies.
Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Tr | 1987 |
Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.
Topics: Adult; Aged; Calcitonin; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hypercalcemia; Hyperth | 1968 |
59 other studies available for hydroxyproline and Hypercalcemia
| Article | Year |
|---|---|
Idiopathic periostitis with hypercalcemia.
Topics: Adult; Calcium; Female; Humans; Hydroxyproline; Hypercalcemia; Magnesium; Periostitis | 1967 |
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproli | 1980 |
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Female; Humans; Hyd | 1983 |
[Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].
Topics: Aged; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Ilium; Injections, Int | 1983 |
Vitamin D3 toxicity in dairy cows.
Topics: 25-Hydroxyvitamin D 2; Animals; Calcifediol; Calcium; Cattle; Cattle Diseases; Cholecalciferol; Ergo | 1982 |
Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.
Topics: Animals; Bone and Bones; Calcitriol; Cyclic AMP; Dinoprostone; Dogs; Hydroxyproline; Hypercalcemia; | 1983 |
[Simple treatment of tumor-induced hypercalcemia: i.v. aminohydroxypropylidene biphosphonate].
Topics: Adenosine Diphosphate; Adult; Aged; Calcium; Cyclic AMP; Female; Humans; Hydroxyproline; Hypercalcem | 1983 |
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Topics: Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Carcinoma, Bronchogenic; | 1984 |
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Diarrhea; Diphosphonates; Dru | 1981 |
Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism.
Topics: Adolescent; Adult; Bone Diseases; Calcitonin; Calcium; Female; Humans; Hydroxyproline; Hypercalcemia | 1981 |
Asymptomatic hyperparathyroidism: an assessment of operative intervention.
Topics: Alkaline Phosphatase; Calcium; Female; Follow-Up Studies; Humans; Hydroxyproline; Hypercalcemia; Hyp | 1980 |
[Biphosphonates and multiple myeloma].
Topics: Animals; Bone Neoplasms; Calcium; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Multiple My | 1993 |
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Topics: Adenoma; Adult; Alkaline Phosphatase; Bone and Bones; Calcitriol; Calcium; Creatinine; Diphosphonate | 1993 |
Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort.
Topics: alpha-Macroglobulins; Animals; Bone Marrow; Bone Resorption; Calcium; Disease Models, Animal; Fractu | 1997 |
Effects of diphosphonate and colchicine administration upon acid-base changes induced in rats by bilateral nephrectomy.
Topics: Acid-Base Equilibrium; Acids; Animals; Colchicine; Etidronic Acid; Hydrogen-Ion Concentration; Hydro | 1979 |
Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
Topics: Bone Resorption; Breast Neoplasms; Calcium; Creatinine; Diphosphonates; Female; Humans; Hydroxyproli | 1979 |
[Malignant hypercalcemia during Basedow's disease].
Topics: Adenoma; Adult; Bipolar Disorder; Bone Resorption; Calcitonin; Calcium; Carbimazole; Graves Disease; | 1975 |
Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism.
Topics: Adult; Female; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; | 1977 |
Immobilization hypercalcemia after single limb fractures in children and adolescents.
Topics: Adolescent; Calcitonin; Calcium; Child; Child, Preschool; Creatinine; Femoral Fractures; Humans; Hyd | 1978 |
A biochemical approach to the staging of human breast cancer.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; C-Reactive Protein; Calcitonin; | 1977 |
[Studies of calcium-phosphorus metabolism in thyrotoxicosis].
Topics: Adult; Calcium; Female; Humans; Hydroxyproline; Hypercalcemia; Hyperthyroidism; Hypothyroidism; Male | 1977 |
Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
Topics: Aspirin; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hype | 1976 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol | 1992 |
Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.
Topics: Adult; Aged; Bone Resorption; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia | 1991 |
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.
Topics: Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Female; Humans; | 1990 |
[Bone turnover markers in tumor pathology with bone involvement].
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Neoplasms; Female; Humans; Hydro | 1990 |
Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Topics: Aged; Alkaline Phosphatase; Calcium-Binding Proteins; Creatinine; Female; Humans; Hydroxyproline; Hy | 1989 |
Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy.
Topics: Adult; Calcitriol; Cyclic AMP; Humans; Hydroxyproline; Hypercalcemia; Leprosy; Male; Parathyroid Hor | 1988 |
Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyprolin | 1987 |
Clodronate in the medical management of hyperparathyroidism.
Topics: Administration, Oral; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hyper | 1987 |
Humoral hypercalcemia of malignancy in nude mouse model of a canine adenocarcinoma derived from apocrine glands of the anal sac. Biochemical, histomorphometric, and ultrastructural studies.
Topics: Adenocarcinoma; Anal Gland Neoplasms; Anal Sacs; Animals; Apocrine Glands; Calcitriol; Calcium; Cycl | 1986 |
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Cyclic AMP; Diphosphonates; Female; Head and | 1986 |
Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
Topics: Adult; Aged; Aged, 80 and over; Calcifediol; Calcitriol; Calcium; Creatinine; Cyclic AMP; Etidronic | 1987 |
Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
Topics: Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Etidronic Acid; Female; Humans; Hydroxyprol | 1987 |
Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Human | 1985 |
Hydroxyprolinuria and hypercalcaemia during immobilization in patients with idiopathic myelofibrosis.
Topics: Adult; Collagen; Female; Humans; Hydroxyproline; Hypercalcemia; Immobilization; Male; Middle Aged; P | 1988 |
Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium-Binding Proteins; Creatinine; Diagnosis, Differential; Fe | 1987 |
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Female; Fluid Therapy; Humans; Hydroxyprolin | 1987 |
Hypercalcemia in glucocorticoid withdrawal.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Calcium; Female; Glucocorticoids; Humans; Hydroxypr | 1986 |
Efficacy of aminohydroxypropylidene diphosphonate in the treatment of malignancy-associated hypercalcaemia.
Topics: Adenosine Diphosphate; Bone Neoplasms; Breast Neoplasms; Calcium; Drug Evaluation; Female; Humans; H | 1987 |
Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Topics: Absorption; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Humans; Hydroxyproline; H | 1985 |
Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
Topics: Adenocarcinoma; Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Child, Presc | 1971 |
Mithramycin in the treatment of Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Blood Urea Nitrogen; Cardiac Output; Female | 1972 |
Hypercalcemia due to hypervitaminosis A.
Topics: Acne Vulgaris; Adolescent; Alkaline Phosphatase; Bone and Bones; Female; Furosemide; Humans; Hydroxy | 1974 |
[Some endocrinological variations of calcium and phosphorus metabolism].
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Edetic Acid; Humans; Hydroxyproline; Hypercalcemia; Hyper | 1973 |
Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation.
Topics: Alkaline Phosphatase; Arteries; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Calcium; Carcinoma, H | 1970 |
Laboratory aids in the diagnosis of metabolic bone disease.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases; Calcium; Calcium, Dietary; Cyclic AMP; | 1972 |
Chronic adult hypervitaminosis A with hypercalcemia.
Topics: Adolescent; Calcium; Humans; Hydroxyproline; Hypercalcemia; Male; Phosphorus; Vitamin A | 1972 |
Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Co | 1971 |
[Immobilization-induced hypercalcemia. A review together with 1 personal case].
Topics: Adolescent; Adrenal Cortex Hormones; Blood Pressure; Calcium; Calcium Sulfate; Creatinine; Femur; Fr | 1971 |
Microradiographic evaluation of bone and ultrastructure of C-cells and parathyroid glands of cows receiving parathyroid extract.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Cattle; Collage | 1971 |
The acute effects of porcine calcitonin in man.
Topics: Adult; Aged; Animals; Bone Resorption; Calcitonin; Calcium; Creatinine; Female; Humans; Hydroxyproli | 1969 |
Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.
Topics: Antibiotics, Antineoplastic; Calcium; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Neop | 1970 |
Renal effects of calcitonin.
Topics: Aged; Animals; Bone Resorption; Breast Neoplasms; Calcitonin; Calcium; Female; Humans; Hydroxyprolin | 1970 |
[Clinical, biochemical and roentgenologic changes in hyperparathyroidism from the viewpoint of the orthopedist].
Topics: Adolescent; Alkaline Phosphatase; Bone Diseases; Calcium; Cleidocranial Dysplasia; Diagnosis, Differ | 1970 |
[Congenital hyperparathyroidism].
Topics: Chromatography, Paper; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Infa | 1968 |
The effect of magnesium deficiency on calcium homeostasis in the rat.
Topics: Animals; Bone and Bones; Calcium; Calcium, Dietary; Diet; Homeostasis; Hydroxyproline; Hypercalcemia | 1969 |
Effects of calcium infusion on urinary hydroxyproline and phosphorus: evaluation as a diagnostic test.
Topics: Acromegaly; Adolescent; Adult; Aged; Calcium; Child; Female; Humans; Hydroxyproline; Hypercalcemia; | 1966 |
Urinary hydroxyproline and calcium metabolism in patients with cancer.
Topics: Bone Neoplasms; Calcium; Humans; Hydroxyproline; Hypercalcemia; Neoplasm Metastasis; Neoplasms; Urin | 1966 |